Table 2.
HPLC analysis.
Protocol | Column | Detection | Derivatization Reagent | Sample Matrix | Limits of Detection | Ref. |
---|---|---|---|---|---|---|
RP-HPLC | Hypersil ODS | Fluorescent | 3-mercaptopropionic acid/o-phthaldehyde | muscle | 0.005 mmol/kg | [32,33] |
RP-HPLC | APEX ODS | Fluorescent | 3-mercaptopropionic acid/o-phthaldehyde | muscle | 0.005 mmol/kg | [34] |
RP HPLC | Hypersil ODS | Fluorescent | 3-mercaptopropionic acid/o-phthaldehyde | muscle | 0.005 mmol/kg | [35] |
JLC-300 | LCR-6 | n.a | n.a. | muscle | 0.005 mmol/kg | [36] |
RP HPLC | XBridge BEH | Fluorescent | AccQTag | muscle | n.a. | [38] |
RP HPLC | Hypersilica | UV (210 nm) | n.a. | muscle | 3 and 10 μM | [41] |
RP HPLC | HILIC silica | UV (214 nm) | n.a | muscle | [39] | |
RP HPLC | Hypersil ODS | Fluorescent | 3-mercaptopropionic acid/o-phthaldehyde | human plasma | [18] | |
UPLC | Acquity Peptide BEH C18 | MS | n.a. | human plasma | [40] | |
RP HPLC | Jupiter C18 | Fluorescent | carbazole-9-carbonyl chloride (CFC) | human serum, animal feed | 15 nM | [28] |